PRECISION BIOSCIENCES INC (DTIL) Debt-to-equity % [USD] 2019 - 2024

Historical data

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Precision Biosciences Inc quarterly Debt-to-equity history and growth rate from 2019 to 2024.
Precision Biosciences Inc Debt-to-equity for the quarter ending March 31, 2024 was 479 %, a 90.9% increase year-over-year.

Debt-to-equity, Quarterly (% [USD])

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q1 2024	479	+228	+90.9%	Mar 31, 2024
Q4 2023	482	+270	+128%	Dec 31, 2023
Q3 2023	382	+206	+117%	Sep 30, 2023
Q2 2023	309	+158	+105%	Jun 30, 2023
Q1 2023	251	+117	+87%	Mar 31, 2023
Q4 2022	211	+46.8	+28.4%	Dec 31, 2022
Q3 2022	176	-8.77	-4.74%	Sep 30, 2022
Q2 2022	151	-52.1	-25.6%	Jun 30, 2022
Q1 2022	134	-68.6	-33.8%	Mar 31, 2022
Q4 2021	165	+32.3	+24.5%	Dec 31, 2021
Q3 2021	185	+85.8	+86.4%	Sep 30, 2021
Q2 2021	203	+122	+152%	Jun 30, 2021
Q1 2021	203	+135	+197%	Mar 31, 2021
Q4 2020	132	+37.1	+39.1%	Dec 31, 2020
Q3 2020	99.2	-20.9	-17.4%	Sep 30, 2020
Q2 2020	80.7			Jun 30, 2020
Q1 2020	68.4			Mar 31, 2020
Q4 2019	95.1			Dec 31, 2019
Q3 2019	120			Sep 30, 2019

* An asterisk sign (*) next to the value indicates that the value is likely invalid.